Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Cancer Medicine|November 1, 2023
Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort studyLinfeng Li, Zhengyu Yu, Jianjun Ren, et al.
Expert Review of Hematology|April 19, 2022
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemiaJinbing Zhu, Qiuji Wu, Jinjin Wang, et al.
Cancer Medicine|June 2, 2023
Efficacy of front-line immunochemotherapy for transplant-ineligible mantle cell lymphoma: A network meta-analysis of randomized controlled trialsCaixia Jing, Ailin Zhao, Jinjin Wang, et al.
Frontiers in Immunology|March 14, 2024
Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trialsXin Wang, Ailin Zhao, Jinbing Zhu, et al.
Frontiers in Pharmacology|May 24, 2019
Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic TrailsHui Zhou, Xiaoyan Fu, Qian Li, et al.
Antioxidants (Basel, Switzerland)|April 29, 2025
Dietary Flavonoid Intake and Anemia Risk in Children and Adolescents: Insights from National Health and Nutrition Examination SurveyLinfeng Li, Zhongwang Wang, Zhengyu Yu, et al.
Molecular Medicine Reports|August 4, 2016
Astaxanthin blocks preeclampsia progression by suppressing oxidative stress and inflammationRong-Rong Xuan, Ting-Ting Niu, Hai-Min Chen
Ecotoxicology and Environmental Safety|November 16, 2025
Bone marrow accumulation of perfluoroalkyl substances (PFASs) predicts post-transplant relapse in acute myeloid leukemia patients and associated with T-cell dysregulationYue Ren, Tong Li, Qiao Chen, et al.
Frontiers in Pharmacology|March 4, 2021
Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJinjin Wang, Ailin Zhao, Hui Zhou, et al.
Oncology Research|April 1, 2024
Development of a cell adhesion-based prognostic model for multiple myeloma: Insights into chemotherapy response and potential reversal of adhesion effectsQian Hu, Mengyao Wang, Jinjin Wang, et al.
Pageof 34